ED medications explained: how PDE5 inhibitors work

How do PDE5 inhibitors work?

When people ask how ED medicationworks, the honest short answer is that it does not create an erection out of nothing. It removes a brake on your body's own machinery. To see why, it helps to follow the chain of events that produces an erection in the first place.

An erection is fundamentally a blood-flow event. During sexual arousal, nerve endings and the cells lining the blood vessels of the penis release a gas called nitric oxide (NO). Nitric oxide switches on an enzyme that produces a signalling molecule called cyclic guanosine monophosphate, or cGMP. That cGMP tells the smooth muscle in the penile arteries and tissue to relax, which lets blood rush in and produces the erection ^[7].

Left alone, cGMP does not last. An enzyme called phosphodiesterase type 5 (PDE5) steadily breaks it down, which is part of how an erection naturally subsides. This is where the medicines get their name: a PDE5 inhibitor blocks that break-down enzyme, so cGMP accumulates rather than being cleared, the smooth muscle stays relaxed for longer, and blood flow is sustained ^[7]. In simple terms, the drug does not push the accelerator — it stops the brake from being applied too soon.

How do the four ED medications compare?

There are four PDE5 inhibitors approved by the US FDA: sildenafil, vardenafil, tadalafil and avanafil ^[7]. They share the same core mechanism but differ in how fast they are absorbed, how long they persist, and how much a meal matters. The table below reports pharmacology facts drawn directly from each drug's FDA prescribing information. It is educational — it deliberately does not rank the molecules or recommend one, because suitability is an individual clinical judgment.

A few plain-language takeaways from those facts. Tadalafil stands apart for its long half-life of 17.5 hours and its documented window of improved erectile function up to 36 hours, which is why it is sometimes described in medical literature as the longer-acting option ^[2]. Avanafil is the newest of the four — its initial US approval was in 2012 — and its label notes it can be taken as early as approximately 15 minutes before sexual activity, though this is a labelling statement about timing, not a promise of results ^[3]. Sildenafil and vardenafil are the more meal-sensitive of the group, with a fatty meal blunting and delaying their absorption ^[1][4].

None of this tells you which molecule is right for a given person. It simply shows that these are genuinely different medicines with different properties, and that matching them to an individual — dose, timing, interactions and all — is a clinical task. Our broader guide to ED treatment options puts these tablets in the context of the full range of approaches.

How effective are ED medications in clinical trials?

“Does it work?” is best answered not by any single anecdote but by pooled trial evidence — and that evidence is best read as population averages, not a personal guarantee. The American Urological Association names oral PDE5 inhibitors as a first-line option that men with ED should be informed about unless contraindicated, and grades that as a strong recommendation ^[13]. It also estimates that up to 30 million men in the US and 150 million worldwide are affected by ED, which is why the evidence base is so large ^[13].

The most comprehensive comparison is a network meta-analysis of 118 randomised trials covering 31,195 men. It found every PDE5 inhibitor superior to placebo, with tadalafil and vardenafil ranked most effective; tadalafil edged vardenafil on the IIEF erectile-function domain (mean difference 1.49; 95% CI 0.50–2.50), and avanafil scored lower than tadalafil and vardenafil on one global assessment question ^[5]. The analysis reported no major safety difference between the agents, describing the class as generally safe and well tolerated ^[5].

When two of the molecules are compared head-to-head, the efficacy gap narrows further. A meta-analysis of 16 trials and 5,189 patients found no statistically significant difference between sildenafil and tadalafil on the IIEF erectile-function change (weighted mean difference 0.03; 95% CI −0.32 to 0.39; P=0.85), and equivalent overall adverse-event rates ^[6]. The notable differences were in side-effect texture and preference: tadalafil produced more back pain and muscle ache but significantly less flushing, and patients strongly preferred it (odds ratio 8.04; 95% CI 4.99–12.96) ^[6].

The honest reading is that these are effective medicines as a class, broadly comparable in raw efficacy, with real differences in duration, timing and side-effect profile. Which of those trade-offs matters for you is not something a statistic can decide — it is what a consultation is for.

What are the side effects of ED medications?

Because these medicines relax smooth muscle and widen blood vessels throughout the body, most of their common side effects follow logically from that. In sildenafil's 100 mg fixed-dose studies (506 men on the drug versus 607 on placebo), headache occurred in 28% versus 7%, flushing in 18% versus 2%, and indigestion (dyspepsia) in 17% versus 2% ^[1]. Tadalafil's 20 mg as-needed data show headache in 15% versus 5% on placebo, dyspepsia in 10% versus 1%, and back pain in 6% versus 3% ^[2].

The pattern holds across the class. Vardenafil's label lists headache in 15% versus 4% and flushing in 11% versus 1% ^[4], and avanafil's reports headache from 6.9% at 100 mg up to 10.5% at 200 mg, with flushing of 3.2–4.3% and nasal congestion of 1.8–2.9% ^[3]. Vardenafil also carries a specific QT-prolongation warning — at 10 mg it produced a QTc increase comparable to moxifloxacin 400 mg — which is one reason a doctor reviews your heart rhythm and other medicines before choosing an agent ^[4].

Why these are prescription-only in India

Given how strict the nitrate interaction is, it is no accident that ED meds are not sold over the counter. In India, sildenafil is a Schedule H drug under the Drugs and Cosmetics Rules, 1945. Schedule H medicines cannot be purchased over the counter without the prescription of a qualified, registered medical practitioner ^[11]. The schedule is revised on the advice of the Drugs Technical Advisory Board within the Central Drugs Standard Control Organization (CDSCO), under the Ministry of Health and Family Welfare ^[11].

This is not a new or fringe category. Pfizer launched branded Viagra in India in December 2005, across 30 cities, roughly seven years after its US debut, targeting an estimated 90 million Indian men with ED ^[14]. The prescription requirement has been part of the picture from the start; the medicine is legitimate, but it is legitimate through a doctor.

Questions your doctor will ask before prescribing

A proper consultation for an erectile dysfunction medication is not a rubber stamp. It is a structured safety check, and knowing what a doctor is looking for helps you understand why the process matters. The questions cluster around a few themes.

Your heart and cardiovascular fitness. Because these drugs affect blood pressure and are absolutely contraindicated with nitrates, a doctor will ask about heart disease, chest pain (angina), recent cardiac events, and every medicine you take — with particular attention to nitrates and blood-pressure drugs ^[1][7]. Since sexual activity itself is a form of exertion, your general cardiac fitness is part of the assessment.

Your other medications.Beyond nitrates, alpha-blockers require caution and stable dosing with monitoring, and vardenafil's QT-prolongation warning means other QT-affecting drugs matter too ^[7][4]. A full medicines list is not a formality; it is how dangerous combinations are caught before they happen.

What is actually causing your ED. A tablet manages the erection mechanism, but it does not address the cause. That matters in India specifically: a community study of 894 rural North Indian men found ED in 5.0% overall, and identified diabetes (odds ratio 2.40) and hypertension (odds ratio 3.17) as independent correlates ^[9]. ED can be an early flag for vascular or metabolic disease, so a good consultation screens for those drivers rather than simply reaching for a prescription. If you want the underlying condition explained first, our guide to erectile dysfunction causes and diagnosis covers it in depth.

The AUA frames the medicine itself as one first-line option to be discussed and, where used, titrated for optimal effect ^[13]. “Titrated” is the key word: the right dose is found with a doctor over time, not guessed. This is the difference between a supervised plan and a gamble.

The bottom line

PDE5 inhibitors are among the best-studied medicines in men's health. They work by protecting the body's own cGMP signal so that a natural, arousal-triggered erection response is sustained — which is also why they do nothing without arousal ^[1][7]. As a class they are effective and generally well tolerated, with real differences between the four molecules in duration, timing and side-effect profile ^[5][6].

But the same properties that make them work — vasodilation through the nitric-oxide pathway — are exactly why they carry an absolute nitrate contraindication and are prescription-only in India under Schedule H ^[2][11]. Add the documented counterfeit trade, and the case for a supervised route is not about caution for its own sake; it is about getting a genuine medicine, at a verified dose, checked against your heart and your other drugs.

No website — including this one — can tell you whether any of these medicines is right for you, which one, or at what dose. That is the independent judgment of a registered medical practitioner after a real assessment. If you would like that conversation, our doctor-led sexual health program is built around exactly this kind of supervised care, and you can start privately with the sexual health assessment.

Frequently asked questions